Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6Z6W

Poliovirus type 3 (strain Saukett) stabilised virus-like particle (PV3 SC8) from a mammalian expression system.

Summary for 6Z6W
Entry DOI10.2210/pdb6z6w/pdb
EMDB information11106
DescriptorCapsid proteins, VP1, Capsid proteins, VP0, Capsid proteins, VP3, ... (4 entities in total)
Functional Keywordscapsid protein, virus like particle
Biological sourceHuman poliovirus 3
More
Total number of polymer chains3
Total formula weight97800.40
Authors
Bahar, M.W.,Porta, C.,Fry, E.E.,Stuart, D.I. (deposition date: 2020-05-29, release date: 2020-12-30, Last modification date: 2024-07-10)
Primary citationBahar, M.W.,Porta, C.,Fox, H.,Macadam, A.J.,Fry, E.E.,Stuart, D.I.
Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines.
NPJ Vaccines, 6:5-5, 2021
Cited by
PubMed Abstract: Global vaccination programs using live-attenuated oral and inactivated polio vaccine (OPV and IPV) have almost eradicated poliovirus (PV) but these vaccines or their production pose significant risk in a polio-free world. Recombinant PV virus-like particles (VLPs), lacking the viral genome, represent safe next-generation vaccines, however their production requires optimisation. Here we present an efficient mammalian expression strategy producing good yields of wild-type PV VLPs for all three serotypes and a thermostabilised variant for PV3. Whilst the wild-type VLPs were predominantly in the non-native C-antigenic form, the thermostabilised PV3 VLPs adopted the native D-antigenic conformation eliciting neutralising antibody titres equivalent to the current IPV and were indistinguishable from natural empty particles by cryo-electron microscopy with a similar stabilising lipidic pocket-factor in the VP1 β-barrel. This factor may not be available in alternative expression systems, which may require synthetic pocket-binding factors. VLPs equivalent to these mammalian expressed thermostabilized particles, represent safer non-infectious vaccine candidates for the post-eradication era.
PubMed: 33420068
DOI: 10.1038/s41541-020-00267-3
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3 Å)
Structure validation

239149

PDB entries from 2025-07-23

PDB statisticsPDBj update infoContact PDBjnumon